Homodetic cyclic peptides targeting alpha-4-beta-7 integrin

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11286281
APP PUB NO 20200095285A1
SERIAL NO

16611518

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is described herein antagonists of α4β7 integrin, and more particularly cyclic peptide antagonists, such as compounds of formula (I).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZEALAND PHARMA A/SSYDMARKEN 11 SØBORG 2860

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hickey, Jennifer L Toronto, CA 10 21
Kafal, Adam Paul Toronto, CA 8 21
Morshed, M Monzur Mississauga, CA 5 18
Roughton, Andrew Port Hope, CA 7 14
Vazquez, Manuel Perez Milton, CA 8 21

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 29, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 29, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 29, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00